[go: up one dir, main page]

GB201515296D0 - Hydrogel compositions, methods for preparing the same and uses thereof - Google Patents

Hydrogel compositions, methods for preparing the same and uses thereof

Info

Publication number
GB201515296D0
GB201515296D0 GBGB1515296.0A GB201515296A GB201515296D0 GB 201515296 D0 GB201515296 D0 GB 201515296D0 GB 201515296 A GB201515296 A GB 201515296A GB 201515296 D0 GB201515296 D0 GB 201515296D0
Authority
GB
United Kingdom
Prior art keywords
preparing
methods
same
hydrogel compositions
hydrogel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB1515296.0A
Other versions
GB2535562A8 (en
GB2535562A (en
GB2535562B8 (en
GB2535562B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Mj Medical Devices Co Ltd
Original Assignee
Chongqing Mj Medical Devices Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Mj Medical Devices Co Ltd filed Critical Chongqing Mj Medical Devices Co Ltd
Publication of GB201515296D0 publication Critical patent/GB201515296D0/en
Publication of GB2535562A publication Critical patent/GB2535562A/en
Application granted granted Critical
Publication of GB2535562B publication Critical patent/GB2535562B/en
Publication of GB2535562A8 publication Critical patent/GB2535562A8/en
Publication of GB2535562B8 publication Critical patent/GB2535562B8/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB1515296.0A 2014-09-30 2015-08-28 Hydrogel compositions and their use in the treatment of symptoms induced by hypertrophic scars Expired - Fee Related GB2535562B8 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB2014088001 2014-09-30

Publications (5)

Publication Number Publication Date
GB201515296D0 true GB201515296D0 (en) 2015-10-14
GB2535562A GB2535562A (en) 2016-08-24
GB2535562B GB2535562B (en) 2017-03-29
GB2535562A8 GB2535562A8 (en) 2017-07-19
GB2535562B8 GB2535562B8 (en) 2017-07-19

Family

ID=54326467

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1515296.0A Expired - Fee Related GB2535562B8 (en) 2014-09-30 2015-08-28 Hydrogel compositions and their use in the treatment of symptoms induced by hypertrophic scars

Country Status (1)

Country Link
GB (1) GB2535562B8 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114748413A (en) * 2022-03-14 2022-07-15 云南贝泰妮生物科技集团股份有限公司 Hydrogel composition for inhibiting scar formation and preparation method and application thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12440427B2 (en) * 2022-08-05 2025-10-14 Denis Simioni Skin dough composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101367105B1 (en) * 2011-10-04 2014-02-26 주식회사 제닉 Hydrogel Composition For Holding Object And Method For Preparing Hydrogel Using the Same
CN103340843B (en) * 2013-07-11 2014-11-05 中国人民解放军第三军医大学第一附属医院 A polymer composite latex scar patch applied in suppressing itching and other discomforts

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114748413A (en) * 2022-03-14 2022-07-15 云南贝泰妮生物科技集团股份有限公司 Hydrogel composition for inhibiting scar formation and preparation method and application thereof
CN114748413B (en) * 2022-03-14 2023-11-28 云南贝泰妮生物科技集团股份有限公司 Hydrogel composition for inhibiting scar formation and preparation method and application thereof

Also Published As

Publication number Publication date
GB2535562A8 (en) 2017-07-19
GB2535562A (en) 2016-08-24
GB2535562B8 (en) 2017-07-19
GB2535562B (en) 2017-03-29

Similar Documents

Publication Publication Date Title
ZA201701168B (en) Antibodies, compositions, and uses
ZA201604831B (en) Hybridosomes, compositions comprising the same, processes for their production and uses thereof
ZA201607573B (en) Novel compositions, uses and methods for making them
EP3155399A4 (en) Viscometer and methods for using the same
EP3228662A4 (en) Composition for gel cushion, and gel cushion manufactured therefrom
PL3157901T3 (en) Formulations, the production and use thereof, and suitable components
SG11201705031VA (en) Hydrogel composition
PT3183295T (en) Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same
GB201715769D0 (en) Methods, Compositions and uses relating thereto
SI3220893T1 (en) Composition based on coq10
PL3166945T3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
GB201715768D0 (en) Methods, compositions and uses relating thereto
GB201706349D0 (en) Methods, compositions and uses relating thereto
GB201616670D0 (en) Methods, compositions and uses relating thereto
IL249122A0 (en) Imidazol- or 1,2,4-triazol-derivatives and their use
EP3237399A4 (en) Compounds, compositions and methods
EP3212699A4 (en) Suspension polymerization compositions, methods and use thereof
EP3145961A4 (en) Zinc containing catalysts, methods for preparing the catalysts, and compositions containing the catalysts
SG11201700276QA (en) Quinoxaline compounds, method for preparing the same and use thereof
GB201515296D0 (en) Hydrogel compositions, methods for preparing the same and uses thereof
GB201715770D0 (en) Methods, compositions and uses relating thereto
GB201715799D0 (en) Methods, compositions and uses relating thereto
GB201616666D0 (en) Methods, compositions and uses relating thereto
GB201616676D0 (en) Methods, compositions and uses relating thereto
GB201616745D0 (en) Methods, compositions and uses relating thereto

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20190828